UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): June 17, 2014
 
 
PHARMERICA CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
 
 
Delaware
001-33380
87-0792558
 
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
1901 Campus Place
Louisville, Kentucky 40299
(Address of principal executive offices) (Zip Code)
 
(502) 627-7000
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Item 5.07 Submission of Matters to a Vote of Security Holders.
 
The 2014 Annual Meeting of Stockholders of the Company was held on June 17, 2014.
 
1. The Company’s stockholders approved the election of the following nine directors for a term to expire at the Annual Meeting of Stockholders in 2015. The votes for each director were as follows:

Name
  
For
    
Withheld Authority
    
Broker Non-Votes
  
Frank E. Collins, Esq.
    
23,209,872
      
2,758,875
      
2,115,482
  
W. Robert Dahl, Jr.
    
25,758,254
      
210,493
      
2,115,482
  
Marjorie W. Dorr
    
25,762,695
      
206,052
      
2,115,482
  
Thomas P. Gerrity, Ph.D.
    
25,517,146
      
451,601
      
2,115,482
  
Patrick G. LePore
    
25,758,658
      
210,089
      
2,115,482
  
Thomas P. Mac Mahon
    
25,758,351
      
210,396
      
2,115,482
  
Geoffrey G. Meyers
    
25,518,811
      
449,936
      
2,115,482
  
Robert A. Oakley, Ph.D.
    
25,759,741
      
209,006
      
2,115,482
  
Gregory S. Weishar
    
25,759,639
      
209,108
      
2,115,482
  
 
2. The Company’s stockholders voted upon the ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2014. The votes on this proposal were as follows:

For
 
Against
 
Abstained
28,014,094
 
49,168
 
20,967
 
3. The Company’s stockholders voted upon and approved, by advisory vote, the compensation of the Company’s named executive officers. The votes on this proposal were as follows:
 
For
 
Against
 
Abstained
 
Broker Non-Votes
24,225,354
 
1,608,500
 
134,893
 
2,115,482

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
PHARMERICA CORPORATION
 
 
 
Date: June 19, 2014
By:
/s/ Thomas A. Caneris
 
 
Thomas A. Caneris
 
 
Senior Vice President, General Counsel, Chief
Compliance Officer, and Secretary